Lv1
50 积分 2026-03-13 加入
Optimizing drug sensitivity assays in patient-derived tumor organoids: a comparison of IC50 estimation methods and experimental parameters
1个月前
已完结
Abstract 217: Establishment of a spatially defined co-culture model of non-small cell lung cancer organoids and cancer-associated fibroblasts to investigate phenotypic heterogeneity
1个月前
已关闭
An Optimized Method to Culture Human Primary Lung Tumor Cell Spheroids
3个月前
已完结
Building consensus on the application of organoid-based drug sensitivity testing in cancer precision medicine and drug development
4个月前
已完结
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
5个月前
已完结
Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non–Small-Cell Lung Cancer in Asia (IPASS)
5个月前
已完结
Evaluation of Perfusion Cell Culture Conditions in a Double-Layered Microphysiological System Using AI-Assisted Morphological Analysis
5个月前
已完结
Evaluation of Perfusion Cell Culture Conditions in a Double-Layered Microphysiological System Using AI-Assisted Morphological Analysis
5个月前
已完结
Artificial Intelligence in Organoid-Based Disease Modeling: A New Frontier in Precision Medicine
5个月前
已完结
Evaluation of Perfusion Cell Culture Conditions in a Double-Layered Microphysiological System Using AI-Assisted Morphological Analysis
5个月前
已完结
皖公网安备34019202002308
